Chemed Corporation (NYSE:CHE)’ President and Chief Executive Officer, Kevin Mcnamara, sold 10,000 shares of Capital Stock on Friday. The stock was disposed directly at a price of $101.00 per share, and the insider also exercised his use of 50,000 stock options. This is the fourth time that the CEO unloaded stock this fiscal year, with the most recent disposition completed in May, when Mcnamara sold 5,000 shares for $85.05 per share.
Timothy Otoole, Executive Vice President at the $1.7 billion market cap healthcare firm, was another insider to complete a stock sale this year. Otoole disposed of 9,000 shares of Common Stock in May, for a price of $87.62 per share.
On another note, this quarter showed movement amongst hedge funds, with several new shareholder positions and increased in Chemed’s portfolio participation. Cliff Asness’ Aqr Capital Management is one the newest shareholding hedge funds, as it recently acquired 9.5 million company shares, with an estimated value of $10.6 million.